Amryt Pharma PLC (NASDAQ:AMYT, LON:AMYT) said it has signed an agreement with Medison Pharma Canada, which will distribute the former’s Myalepta drug in the country.
It completes the multi-regional distribution deal with Medison announced in February for two products, the other being Lojuxta/Juxtapid.
Chief executive, Dr Joe Wiley, said: “Today’s announcement represents continued progress as we grow our commercial assets and expand access to treatment for patients in existing and new territories.
“We are also pleased to extend our engagement with Medison and further benefit from their expertise in Canada and other territories.”
The company is focused on developing and commercialising drugs for rare ailments. Myalepta has been approved for the complications of leptin deficiency, while Lojuxta is a lipid-lowering treatment.
Story by ProactiveInvestors
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 888-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Order by Phone at 888-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
pathogens and gives you more
energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video)
Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.